Abstract
Given that the rationale for empirical antifungal therapy in neutropenic children is limited and based on adult patient data, we performed a prospective, randomized, controlled trial that evaluated 110 neutropenic children with persistent fever. Those at high risk for invasive fungal infections (IFI) received caspofungin (Arm C) or liposomal amphotericinB (Arm B); those with a lower risk were randomized to receive Arm B, C, or no antifungal treatment (Arm A). Complete response to empirical antifungal therapy was achieved in 90/104 patients (86·5%): 48/56 at high risk (85·7%) [88·0% in Arm B; 83·9% in Arm C (P = 0·72)], and 42/48 at low risk (87·5%) [87·5% in control Arm A, 80·0% Arm B, 94·1% Arm C; (P = 0·41)]. None of the variables tested by multiple logistic regression analysis showed a significant effect on the probability to achieve complete response. IFI was diagnosed in nine patients (8·2%, 95% confidence interval, 3·8-15·0). This randomized controlled study showed that empirical antifungal therapy was of no advantage in terms of survival without fever and IFI in patients aged <18 years and defined with low risk of IFI. Higher risk patients, including those with relapsed cancer, appear to be the target for empirical antif...Continue Reading
References
Jun 1, 1989·The American Journal of Medicine
Jan 1, 1982·The American Journal of Medicine·P A PizzoF G Witebsky
Jul 17, 1999·Statistics in Medicine·A C Atkinson
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AbbasiP M Flynn
Nov 5, 1999·Mycoses·A H GrollD Schwabe
Apr 3, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P S GaynonH N Sather
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrLawrence Corey
Aug 6, 2002·Controlled Clinical Trials·Boris Freidlin, Edward L Korn
Apr 12, 2003·Blood·Takahiro FukudaKieren A Marr
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Mar 8, 2005·Journal of Pediatric Hematology/oncology·Galit P RosenTheodore B Moore
Apr 9, 2005·The Pediatric Infectious Disease Journal·William J Steinbach
Jan 6, 2006·Pediatric Blood & Cancer·Liisa HoviMalcolm Richardson
Mar 15, 2006·Pediatrics·Theoklis E ZaoutisWilliam J Steinbach
Jun 29, 2006·The Pediatric Infectious Disease Journal·Elio CastagnolaMario R Rossi
Dec 13, 2006·Pediatric Blood & Cancer·Simone CesaroElio Castagnola
Feb 8, 2008·Mycoses·Nicolas CrassardYves Bertrand
May 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ben De PauwUNKNOWN National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Dec 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter BaderUNKNOWN ALL-REZ BFM Study Group
Mar 14, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine CordonnierMichaël Schwarzinger
Jul 9, 2009·Bone Marrow Transplantation·P LjungmanUNKNOWN European Group for Blood and Marrow Transplantation
Jan 26, 2010·British Journal of Haematology·Katherine A HaleTania C Sorrell
May 1, 2010·The Pediatric Infectious Disease Journal·Johan A MaertensUNKNOWN Caspofungin Pediatric Study Group
Jan 5, 2011·The Journal of Antimicrobial Chemotherapy·Livio PaganoNicole Blijlevens
Citations
Oct 30, 2015·Infectious Diseases·A PerrellaW Santaniello
Mar 2, 2013·Pediatric Blood & Cancer·Parth S MehtaUNKNOWN Working Group on Essential Medicines of the Pediatric Oncology in Developing Countries committee of SIOP
Oct 29, 2014·Mycoses·Athanasios TragiannidisAndreas H Groll
Jul 6, 2014·The Lancet Oncology·Andreas H GrollUNKNOWN European Leukaemia Net (ELN)
Jul 2, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas F PattersonJohn E Bennett
May 2, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas LehrnbecherLillian Sung
Mar 13, 2014·The Pediatric Infectious Disease Journal·David F BesElvira Arrizurieta
Sep 5, 2014·The Cochrane Database of Systematic Reviews·Peter C Gøtzsche, Helle Krogh Johansen
Aug 5, 2015·Journal of Korean Medical Science·Seung Beom HanSoo Ah Im
Mar 30, 2018·The Pediatric Infectious Disease Journal·Magdalini TsekouraEmmanuel Roilides
Nov 22, 2018·Current Opinion in Pediatrics·Thomas Lehrnbecher
Jun 1, 2019·Expert Review of Anti-infective Therapy·Thomas Lehrnbecher
Jun 22, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andreas H GrollRoger J M Brüggemann
Mar 29, 2020·JCO Global Oncology·Mario MelgarSheena Mukkada
Jul 6, 2020·British Journal of Haematology·Andreas MerykRoman Crazzolara
May 23, 2014·Expert Review of Molecular Diagnostics·Nicasio ManciniMassimo Clementi
Feb 14, 2019·Journal of Fungi·Savvas PapachristouEmmanuel Roilides
Feb 22, 2017·BMC Infectious Diseases·Ken ChenSuodi Zhai
Apr 4, 2021·The Lancet Oncology·Andreas H GrollUNKNOWN 8th European Conference on Infections in Leukaemia